Laura B. Dunn
Chair and Professor
Also affiliated: California Department of Education (2002); Accenture (Switzerland) (2009); Apple (Israel) (2015–2023); Memorial Sloan Kettering Cancer Center (2013); American Institute of Biological Sciences (2017); Kaiser Permanente (2011); Flinders University (2025); University of Pittsburgh (2017–2024); Lion Corporation (Japan) (2013); Palo Alto University (2017–2019); University of California, San Francisco (2007–2022); Neurosciences Institute (2018); SUNY Upstate Medical University (2021); Medical College of Wisconsin (2008–2009); VA Palo Alto Health Care System (2017); University of South Florida (2013); Brown University (2024); University of Arkansas Medical Center (2022); UC San Diego Health System (2006); East London NHS Foundation Trust (2024); University College Lahore (2008); Langley Porter Psychiatric Hospital and Clinics (2014); University of California System (2003–2023); University of California San Diego (2001–2025); Institutul National de Sanatate Publica (2017); Office of the Director (2023); Unity Health System (2011); SteelCloud (United States) (2011–2024); VA San Diego Healthcare System (2002–2008); Protein Express (United States) (2015); Górnośląskie Centrum Medyczne (2022); San Diego Hospice and The Institute for Palliative Medicine (2012); Levi Strauss (United States) (2011–2024); University of California San Francisco Medical Center (2014); Department of Physiological Sciences (2015); National Health Insurance Fund (2011); Dana-Farber Cancer Institute (2022); Kaiser Permanente San Francisco Medical Center (2011); Mayo Clinic in Arizona (2011); University of Applied Management Studies (2025); University of California San Diego Medical Center (2008); University of Pittsburgh Medical Center (2021); UCSF Benioff Children's Hospital (2014); Stanford Medicine (2016–2021); Alta Bates Summit Medical Center (2011); Institute for Tourism (2014); Swift Engineering (United States) (2011); Health and Human Development (2HD) Research Network (2024); Psychiatric Medical Center (2019); Ecosystem Sciences (2009); Francisco Muñoz Irles (Spain) (2019); UCSF Helen Diller Family Comprehensive Cancer Center (2011–2015); University College London (2009–2013); Imperial College London (2014); University of Greenwich (2000); New York University (2016); University of San Francisco (2011–2013); Columbia University (2007–2008); Stanford University (2007–2022); Icahn School of Medicine at Mount Sinai (2024)
Faculty Researcher
Psychiatry, College of Medicine
Upstream record may be merged OpenAlex, the source of these figures, lists 63 institutions in 16 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Laura B. Dunn holds the Chair and Professor position in the Department of Psychiatry at the University of Arkansas for Medical Sciences, College of Medicine. Her scholarly work encompasses a broad range of topics, including oncology patient symptomology, child safety, and ethical considerations in machine learning. Dunn's research has investigated distinct profiles of co-occurring symptoms in patients undergoing chemotherapy for gastrointestinal cancers, examining associations between stress, resilience, symptom severity, and depressive symptom profiles.
In the domain of public health and injury prevention, Dunn has contributed to studies on intimate partner violence, focusing on the pediatrician's role, as well as child pedestrian safety and the epidemiology of child pedestrian injury. Her work also addresses child fatality review processes. Furthermore, Dunn has explored the perspectives of physicians and machine learning researchers on ethical issues surrounding the early development of clinical machine learning tools.
With a distinguished academic record, Dunn has an h-index of 60 and has accumulated over 12,996 citations across 309 publications. She is recognized as a highly cited researcher and maintains an active research group. Key collaborators include Tatiana Wolfe, Clint Kilts, Srinivasa Gokarakonda, and Michael J. Mancino, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 60
- Publications: 309
- Citations: 13,089
Selected Publications
-
Associations of personality profiles with stress and resilience characteristics among patients undergoing cancer chemotherapy (2026)
-
How to Network and Be a Good Colleague (2025)
-
How to Write Socially (2025)
-
484 A Preliminary Study on the Pharmacodynamics of Oral Cannabis Ingestion in Older Adults (2024)
-
Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients (2024)
-
Becoming an Authentic, Resilient Leader: An Interactive Workshop to Enhance Your Abilities to Lead (2024)
-
Physicians’ and Machine Learning Researchers’ Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study (2023)
-
Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster (2023)
-
Is it worth it? Greater risk aversion with lower life satisfaction among depressed individuals (2023)
-
Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders (2023)
-
Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues (2023)
-
Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers (2023)
-
Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy (2022)
-
Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer (2022)
-
Depression trajectories among women undergoing chemotherapy. (2022)
Collaboration Network
Top Collaborators
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Depression trajectories among women undergoing chemotherapy.
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Depression trajectories among women undergoing chemotherapy.
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study
- Introduction to Our Project: Understanding Ethically Salient Perspectives of Diverse Societal Stakeholders in Innovative Neuroscience Research on Mental Disorders
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Depression trajectories among women undergoing chemotherapy.
- Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
- Depression trajectories among women undergoing chemotherapy.
- Clinical Neuroinnovation: Ethical Frameworks and Emerging Issues
- Qualitative Findings: Diverse Stakeholder Perspectives on Ethical Considerations in Innovative Neuroscience Research Involving Human Volunteers
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
- Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes
Similar Researchers
Based on overlapping research topics